Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Bausch Health Companies Investigation Pharmaceutical Investing
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months Pharmaceutical Investing
Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10 Pharmaceutical Investing
Medtronic and GE Healthcare announce a collaboration to meet growing need for outpatient care Medical Device Investing
GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Care Medical Device Investing
Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation Pharmaceutical Investing
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer Steerable Delivery Sheath for the Company's Amulet Device Pharmaceutical Investing
New Analysis Shows that Abbott's FreeStyle Libre® System Provides Similar and Sustained Reductions in Glucose Levels for People with Both Type 1 and Type 2 Diabetes Pharmaceutical Investing
Ortho Dermatologics Will Present Data at the 2022 Florida Society of Dermatology Physician Assistants New Wave Dermatology Conference Pharmaceutical Investing